Shearman & Sterling represented Quest Diagnostics Incorporated in a shelf takedown of $500 million aggregate principal amount of its 3.450% senior notes due 2026. Goldman, Sachs & Co., Mizuho Securities USA Inc. and Wells Fargo Securities, LLC acted as joint book-running managers for the offering.

Quest Diagnostics Incorporated is the world’s leading provider of diagnostic information services.

The Team